Eurofins Advinus

  Providing R&D services for the discovery and development of compounds for diverse industries including Biologicals, Pharmaceuticals, Agrochemicals, Cosmetics and Nutraceuticals.  

[eurofinsadvinus]

📢 𝐀𝐧𝐨𝐭𝐡𝐞𝐫 𝐦𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞 𝐚𝐜𝐡𝐢𝐞𝐯𝐞𝐝! 🎉 Eurofins Agroscience Services India has received GLP Certification for conducting bio-efficacy studies on Household Insect Pests (HHI). Our studies ensure scientific integrity and regulatory compliance for your pest control products. This certification reinforces our commitment to quality, compliance, and reliable data for the development and registration of house hold pest control products. Our certified scope covers a wide range of HHI bio-efficacy studies to support your product evaluation and registration. 📩 Partner with us for robust, regulatory-compliant testing solutions!

[eurofinsadvinus]

Nitrosamine drug substance-related impurities (NDSRIs) are a class of nitrosamine impurities observed in APIs and drug products. Recent regulatory guidance warrants the evaluation of carcinogenicity risk from nitrosamines. It is necessary to investigate the potential for metabolic activation of NDSRIs and the stability/reactivity of the resulting metabolites. We offer the following nitrosamine metabolism studies in human liver microsomes and hepatocytes - ▶️ Metabolic stability ▶️ Metabolite identification ▶️ Reactive metabolite trapping using glutathione Uncover nitrosamine risks before they become regulatory hurdles – Contact us 📧 [email protected]

[eurofinsadvinus]

If🎉 Exciting news! We are proud to announce that Eurofins BioPharma Product Testing India has successfully completed a US FDA surveillance inspection at our state-of-the-art 24,000+ sq. ft. facility in Bengaluru from June 16 to June 20 covering Chemical, Microbiology, and Stability testing services. This significant achievement reflects our commitment to quality, compliance, and operational excellence. Here is what differentiates us: > A team of 50+ analytical scientists with multifaceted expertise > Track record of delivering complex Nitrosamines analysis projects > Expertise in Extractables & Leachables studies > 1,00,000 L of stability storage monitored 24/7 > 21 CFR Part 11 validated systems ensuring data integrity 👏 A big congratulations to our entire team for their relentless dedication and hard work that made this success possible. We also extend our heartfelt thanks to our customers and partners for their continued trust and support.

[eurofinsadvinus]

🚀 Big news from Eurofins Discovery! We’ve expanded our global chemistry capabilities across the USA, UK, Europe, and India to help you accelerate drug discovery — with more proximity, flexibility, and control. 🔬 300+ chemistry experts 🌍 Global presence ⚙️ Integrated with biology & automation 💼 Flexible FTE & FFS models 💊 Proven success across small molecules, peptides, ADCs & more Whether you're advancing small molecules, covalent inhibitors, peptides, ADCs, or novel modalities, our chemistry services are designed to accelerate timelines and support the development of safe and effective drug candidates, while protecting your IP. 📖 Read more in our latest news release - https://lnkd.in/gHqbM3jU Connect with our experts - [email protected]

[eurofinsadvinus]

🔍 Understanding Drug-Drug Interactions (DDIs) In a complex treatment landscape, patients are often on multiple therapies. That’s why Drug-Drug Interaction (DDI) studies are not just good science—they’re a regulatory necessity. 💡 Why Do Regulators Require DDI Studies? To ensure patient safety, agencies like the US FDA, EMA, and CDSCO mandate a thorough understanding of how a new drug may interact with others. DDI evaluations help: >> Prevent adverse effects or loss of efficacy >> Define contraindications or dosage adjustments >> Inform labelling and clinical use guidelines ✅ What Makes DDI Evaluation Successful? >> Mechanistic understanding (CYP450/UGT inhibition, induction, transporter effects) >> Well-designed in vitro and in vivo studies >> PBPK modelling to predict interactions >> Timely regulatory consultation for study design and expectations >> Integrated risk assessment early in development At Eurofins Advinus, our team supports end-to-end DDI assessment—from study design to regulatory submissions—aligned with international guidelines. 🧪 Want to ensure your molecule is ready for global markets? Let’s talk about building a strong DDI strategy. [email protected]

[eurofinsadvinus]

𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐚𝐠𝐞𝐧𝐜𝐢𝐞𝐬 𝐦𝐚𝐲 𝐫𝐞𝐪𝐮𝐢𝐫𝐞 𝐉𝐮𝐯𝐞𝐧𝐢𝐥𝐞 𝐀𝐧𝐢𝐦𝐚𝐥 𝐓𝐨𝐱𝐢𝐜𝐨𝐥𝐨𝐠𝐲 (𝐉𝐀𝐒) 𝐬𝐭𝐮𝐝𝐢𝐞𝐬 𝐛𝐞𝐟𝐨𝐫𝐞 𝐢𝐧𝐢𝐭𝐢𝐚𝐭𝐢𝐧𝐠 𝐩𝐚𝐞𝐝𝐢𝐚𝐭𝐫𝐢𝐜 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬—𝐞𝐬𝐩𝐞𝐜𝐢𝐚𝐥𝐥𝐲 𝐰𝐡𝐞𝐧 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐚𝐥 𝐭𝐨𝐱𝐢𝐜𝐢𝐭𝐢𝐞𝐬 𝐚𝐫𝐞 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝. When toxicities can’t be measured in early human studies, these preclinical safety assessments fill in the gaps. Each study for this is uniquely designed—tailored to your compound, patient age group, and organ systems of concern like neurological, reproductive, or skeletal. Our team has supported global sponsors with customized, GLP-compliant juvenile toxicity studies—combining regulatory expertise with a deep understanding of pediatric development. ✅ Over 20+ juvenile rodent studies completed successfully across varied dosing routes ✅ Case-by-case protocol planning ✅ Global registration alignment Looking for a CRO that speaks both science and strategy? Let’s design your next juvenile toxicology study together. Connect with our experts – [email protected]

[eurofinsadvinus]

🚀 From Complex to Efficient: Mastering Multistep RSM Synthesis at Eurofins CDMO India Complex syntheses can often lead to inefficiencies. At Eurofins CDMO India, we specialize in converting intricate multistep routes into robust, high-throughput manufacturing processes. Our secret? A deep dive into unit operation studies. By meticulously analysing each step, we identify areas for optimization, leading to significant gains in efficiency, yield, and cost-effectiveness. Ready to transform your complex synthesis into a streamlined success? Contact us to learn how our unit operation expertise can benefit your project 📧 [email protected]

[eurofinsadvinus]

🔬 Microbial Limit Testing is a vital step in safeguarding pharmaceuticals, biopharmaceuticals, and medical devices—but it's not without its complexities. Eurofins BioPharma Product Testing India provides comprehensive microbial limit testing services including: ✅ Method development ✅ Method validation/verification ✅ Batch analysis Key challenges we help you overcome: 🔹 Complex product matrices – Some formulations contain preservatives or active ingredients that can inhibit microbial growth, making detection difficult without tailored methods. 🔹 Method robustness and reproducibility – Ensuring consistent results across batches and labs requires carefully designed and validated methods. 🔹 Global regulatory compliance – Navigating varying requirements (USP, EP, JP, IP, etc.) demands deep regulatory expertise and documentation accuracy. 🔹 Contamination control – Even minor lapses during sample handling or testing can lead to false positives/negatives, impacting product release and patient safety. Our solutions are designed to address these challenges—ensuring your products meet the highest standards of quality, compliance, and safety.

[eurofinsadvinus]

💊 Understanding Drug-Drug Interactions: A Critical Step in Drug Development 💊 Did you know that drug interactions can significantly impact patient safety and treatment efficacy? When two or more medications are taken together, their combined effects can be unpredictable – either potentiating a drug's action, potentially leading to overdose-like responses, or diminishing its effect, making the therapy less effective. These interactions are a vital consideration in drug development to ensure patient safety and optimal therapeutic outcomes. At Eurofins Bioanalytical Services, India , our expert team specializes in conducting comprehensive studies to evaluate drug-drug interactions. We provide the crucial data needed to understand how your compound behaves in combination with other medications, helping you navigate potential risks and ensure responsible drug development. Connect with our team today to discuss your specific drug-drug interaction study requirements and enhance the safety profile of your therapeutic candidates.

[eurofinsadvinus]

𝐈𝐬 𝐲𝐨𝐮𝐫 𝐛𝐥𝐨𝐨𝐝-𝐜𝐨𝐧𝐭𝐚𝐜𝐭𝐢𝐧𝐠 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐢𝐜𝐞 𝐡𝐞𝐦𝐨𝐜𝐨𝐦𝐩𝐚𝐭𝐢𝐛𝐥𝐞? Understanding the impact of your device on the complement system is crucial for patient safety. We offer comprehensive Complement System Testing to ensure your medical device does not adversely affect this vital part of the innate immune system affecting coagulation. 𝐄𝐧𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞 𝐬𝐚𝐟𝐞𝐭𝐲 𝐚𝐧𝐝 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞 - connect with us to learn more about our biocompatibility testing services and how we can help you evaluate the complement compatibility of your medical device.

[eurofinsadvinus]

𝐒𝐩𝐞𝐞𝐝 𝐚𝐧𝐝 𝐫𝐞𝐥𝐢𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐦𝐚𝐭𝐭𝐞𝐫 𝐰𝐡𝐞𝐧 𝐲𝐨𝐮'𝐫𝐞 𝐦𝐚𝐤𝐢𝐧𝐠 𝐞𝐚𝐫𝐥𝐲-𝐬𝐭𝐚𝐠𝐞 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬. At Eurofins Safety Toxicology India our high throughput hERG patch clamp assay supports simultaneous multi-cell recordings — enabling ICH-compliant cardiac safety data that keeps your timelines on track. ▶️ Preliminary results within 24 hours ▶️ High-throughput screening, rapid turnaround ▶️ Ideal for regulatory submissions and discovery stage Whether you're moving fast or filing globally, our platform is built for both agility and assurance. 📩 Get in touch to discuss your study needs [email protected]

[eurofinsadvinus]

When a medical device interacts with blood, even minor surface changes can disrupt clotting—posing risks to both safety and regulatory approval. At Eurofins Safety Toxicology India , we understand what's at stake - That’s why our Coagulation Testing services are: ▶️ Scientifically rigorous and GLP-compliant ▶️ Built to align with ISO 10993-4 requirements ▶️ Designed to detect pro-coagulant or anti-coagulant responses early Whether you're developing a stent, catheter, or implantable system—ensure your innovation doesn't compromise the body’s natural clotting process. We deliver comprehensive #HemocompatibilityStudies to ensure precision testing and regulatory readiness.

[eurofinsadvinus]

Struggling with the rigorous demands /complexity of pharmaceutical stability studies? At Eurofins BioPharma Product Testing India , we simplify the process and our end-to-end stability study services safeguard your product’s quality, safety, and efficacy—throughout its shelf life. From protocol design to storage and testing, we deliver full support under ICH Q1A (R2) guidelines, with our experienced team ✅ ICH-compliant storage across conditions ✅ 24/7 monitored chambers with robust backup systems ✅ Physical, chemical, and microbial stability testing ✅ Custom solutions for Climatic Zones III & IVA ✅ Clear, compliant stability summary reports Whether you're in early development or approaching regulatory submission, we’ll help keep your formulations stable—and your timelines on track. 📩 Reach out to discover how we can support your next product - [email protected]

[eurofinsadvinus]

🔬 𝐍𝐞𝐞𝐝 𝐝𝐞𝐞𝐩𝐞𝐫 𝐢𝐧𝐬𝐢𝐠𝐡𝐭 𝐢𝐧𝐭𝐨 𝐭𝐡𝐞 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐤𝐢𝐧𝐞𝐭𝐢𝐜𝐬 𝐚𝐧𝐝 𝐭𝐢𝐬𝐬𝐮𝐞 𝐝𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐨𝐟 𝐢𝐫𝐨𝐧 𝐟𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬? Understanding how iron-based therapies behave in the body is crucial—especially for improving safety, efficacy, and targeted delivery. We offer comparative pharmacokinetic and tissue distribution study for 🧪 Iron Sucrose Formulation 🧪 Ferric Carboxymaltose Formulation 💡 𝐖𝐡𝐲 𝐢𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬: Iron therapies often involve complex binding and transport mechanisms. To support your drug development goals, our validated ICP-MS methods unlock insights into total, transferrin-bound, and drug-bound iron in tissues and serum — helping you advance safer, more targeted therapies. Our methods offer high sensitivity, precision, and compliance—providing the data needed to make informed decisions in preclinical development. 📈 Partner with us to generate reliable, actionable insights that accelerate your path to market.

[eurofinsadvinus]

Are you seeking robust data on the long-term impact of your chemical and agrochemical products on honeybee health? Regulatory bodies worldwide, including EPA, JMAFF, and EC, emphasize the importance of understanding chronic oral toxicity in adult honeybees. Eurofins Agroscience Services India offers a specialized 10-day feeding study adhering strictly to OECD Guideline 245. Our study meticulously evaluates the chronic effects of your test items on 2-day-old worker bees, providing critical endpoints such as LC50, LD50, NOEC/LOEC, and their dose-dependent equivalents. We also rigorously confirm test system suitability using a reference chemical and analyze diet stability. Elevate your risk assessment strategy with our trusted honeybee chronic toxicity testing services. Reach out to our scientific experts to discuss your specific testing requirements. 📧 [email protected]

[eurofinsadvinus]

Seeking reliable and robust stability study services? We offer state-of-the-art fully GMP complaint solutions with a focus on data integrity and regulatory compliance. 🌏 Our qualified walk-in stability chambers accommodate a range of storage environmental conditions, including 25°C/60%RH, 30°C/65%RH, 30°C/75%RH, 40°C/75%RH, and 5°C, catering to diverse product requirements and climatic zone simulations. We go beyond standard testing. Our comprehensive services encompass protocol preparation, meticulous sample management, proper documentation, access controls, full traceability, and thorough physical, chemical, and microbial analyses. Benefit from our 21 CFR Part 11 compliant monitoring systems, complete with remote alarms and SMS notifications, ensuring the continuous integrity of your stability studies. Trust Eurofins BioPharma Product Testing India for stability studies that deliver accurate data and peace of mind. Contact us to discuss your specific needs.

[eurofinsadvinus]

The team at Eurofins Advinus, offers comprehensive safety assessment services to support every stage of vaccine development, helping bring safe and effective immunizations to the world. Learn more about how we can support your vaccine programs.